The Ophthalmic Drugs Market report titled “Ophthalmic Drugs Market Research Report - Forecast to 2023” is an expert analysis report which summarizes Market Scenario by major Indications, Drugs Class, Dosage and Products in-depth.
pune, India -- (SBWIRE) -- 05/11/2018 -- Market Research Future published a research report on Global Ophthalmic Drugs Market and predicts that Global Ophthalmic Drugs Market is expected to grow at a healthy CAGR of 6.0% during the forecasted period and report include market Analysis, Scope, Stake, Progress, Trends and forecast till 2023.
Owing to the rising cases of eye diseases, the demand for an effective treatment option has also been escalating. In the recent years, various new and existing marketers have come up with effective drugs. For instance, in November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension.
A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are a few factors propelling the growth of the Global Ophthalmic Drugs Market.
It is estimated that the Ophthalmic Drugs Market is expected to grow at a CAGR 6.0% during the forecast period of 2017 to 2023.
To explore more, get PDF sample copy @ https://www.marketresearchfuture.com/sample_request/5753 .
Key Players for Global Ophthalmic Drugs Market
Some of the key players in the Global Ophthalmic Drugs Market are Actavis Generics, Allergan Plc, Bausch & Lomb Inc., Genentech, Inc., Merck & Co., Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Shire Plc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Inc., and others.
Segments for Global Ophthalmic Drugs Market
The Global Ophthalmic Drugs Market is segmented on the basis of indication, drug class, type of dosage, product, distribution channel.
On the basis of indication, the market is classified as glaucoma, retinal disorders, inflammation/infection, dry eye, allergies, uveitis, and others.
On the basis of the drug class, the market is classified as antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma, and others. The anti-inflammatory class is further segmented into nonsteroidal drugs and steroidal drugs.
On the basis of type of dosage, the market is classified as eye drops, eye solutions, ointments, capsules and tablets, and gels.
On the basis of the product, the market is classified as prescription drugs and OTC drugs.
On the basis of the distribution channel, the market is classified as hospital pharmacies, online pharmacies, drug stores, and others.
Regional Analysis for Global Ophthalmic Drugs Market
The Americas dominates the Ophthalmic Drugs Market owing to the presence of patient population, rising prevalence of eye diseases, well-developed technology, high healthcare expenditure, and the presence of the leading players.
Europe holds the second position in the Ophthalmic Drugs Market. It is expected that the government support towards research and development expenditure, increasing competition among marketers, and amendments in reimbursement policies in healthcare are likely to drive the European market.
Asia Pacific is the fastest growing Ophthalmic Drugs Market owing to a huge patient pool, increasing demand, and development in healthcare technology.
The Middle East and Africa hold the lowest share of the Global Ophthalmic Drugs Market due to low development, lack of technical knowledge, and poor medical facilities.
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/5753 .
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
Do You Have Query? Ask To Our Experts @ https://www.marketresearchfuture.com/enquiry/5753 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.